Evidence map›Paper›PMID 27990437›Full record

ArticleBioMed research international2016

Enhanced Performance and Mode of Action of a Novel Antibiofilm Hydrofiber® Wound Dressing.

David Parsons, Kate Meredith, Victoria J Rowlands, Darryl Short, Daniel G Metcalf, Philip G Bowler

Abstract read
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Development ofMolecular pharmaceutics · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Development of Rapid and Economic In Vitro Assay and Biorelevant Ex Vivo Biofilm Inhibition Wound Model to Test the Antibacterial Efficacy of Wound Dressings.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David ParsonsScience & Technology, ConvaTec GDC, First Avenue, Deeside Industrial Park, Flintshire CH5 2NU, UK.
Kate MeredithMicrobiology Services, Research & Development, ConvaTec GDC, First Avenue, Deeside Industrial Park, Flintshire CH5 2NU, UK.ORCID 0000-0003-2861-8948
Victoria J RowlandsMicrobiology Services, Research & Development, ConvaTec GDC, First Avenue, Deeside Industrial Park, Flintshire CH5 2NU, UK.ORCID 0000-0001-5130-2920
Darryl ShortAnalytical Services, Research & Development, ConvaTec GDC, First Avenue, Deeside Industrial Park, Flintshire CH5 2NU, UK.ORCID 0000-0002-1762-5125
Daniel G MetcalfScience & Technology, ConvaTec GDC, First Avenue, Deeside Industrial Park, Flintshire CH5 2NU, UK.ORCID 0000-0002-4814-7533
Philip G BowlerScience & Technology, ConvaTec GDC, First Avenue, Deeside Industrial Park, Flintshire CH5 2NU, UK.ORCID 0000-0003-2977-4862

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilm development in wounds is now acknowledged to be a precursor to infection and a cause of delayed healing. A next-generation antibiofilm carboxymethylcellulose silver-containing wound dressing (NGAD) has been developed to disrupt and kill biofilm microorganisms. This

Indexed as

Bacterial Physiological PhenomenaBandagesBacteriaBiofilmsCarboxymethylcellulose SodiumSilverWound InfectionCarboxymethylcellulose SodiumSilver

Identifiers

PMID27990437
PMCPMC5136405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.